Long-term Outcome of Cardiovascular Prevention: A Nijmegen Academic Family Practices Network Study

References

1. ↵
   van Weel C. Chronic diseases in general practice: the longitudinal dimension. Eur J Gen Pract 1996; 2.
2. ↵
   Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383–90.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occuring chronic and recurrent diseases. J Clin Epidemiol 1998; 51: 367–75.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Rose G. Sick individuals and sick populations. Int J Epidemiol 2001; 30: 427–32.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertension 2000; 13: 3S–10S.

   OpenUrlPubMedWeb of Science
6. ↵
   Primatesta P. Guidelines and risk factor management. Heart 2005; 91: 417–8.

   OpenUrlAbstract/FREE Full Text
7. ↵
   Pringle M. Current targets: where are we today. Heart 2003; 89: ii10–2.

   OpenUrlAbstract/FREE Full Text
8. ↵
   van Weel C, Smith H, Beasley JW. Family practice research networks. Experience from three countries. J Fam Pract 2000; 49: 938–43.

   OpenUrlPubMedWeb of Science
9. ↵
   van Weel C. Longitudinal research and data collection in primary care. Ann Fam Med 2005; 3(Suppl 1): S46–51.

   OpenUrl
10. ↵
    de Grauw WJC, Gerwen van WHEM, Lisdonk van de EH, Hoogen van den HJM, Bosch van den WJHM, Weel van C. Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. J Fam Pract 2002; 51: 459–464.

    OpenUrlPubMedWeb of Science
11. ↵
    van Ree JW. The Nijmegen Intervention Project [thesis]. Nijmegen: University of Nijmegen; 1981.
12. ↵
    Katan MB, van der Haar F, Kromhout D, Schouten FJM. Standardisation of serum cholesterol assays by use of serum calibrators and direct addition of Liebermann-Burchard reagent. Clin Chem 1982; 28: 683–6.

    OpenUrlAbstract/FREE Full Text
13. ↵
    Coronary Risk Handbook. Estimating risk of coronary heart disease in daily practice. Dallas (TX): American Heart Association; 1973.
14. ↵
    Anonymous. ICHPPC-2 defined. Inclusion criteria for the use of the rubrics of the International Classification of Health Problems in Primary Care. Oxford (UK): Oxford University Press; 1983.
15. ↵
    Walma EP, Thomas S, Prins A, Grundmeijer HGLM, van der Laan JR, Wiersma TJ. NHG-Standaard Hypertensie (3e herziening). HuisartsWet 2003; 46: 435–49. Available from: http://nhg.artsennet.nl/upload/104/5989/hypertensie.pdf (accessed 8 May 2005).

    OpenUrl
16. ↵
    Bakx JC, van den Hoogen HJM, van den Bosch WJ, et al. Development of blood pressure and incidence of hypertension in men and women over an 18 years period. J Clin Epidemiol 1999; 52: 531–8.

    OpenUrlCrossRefPubMedWeb of Science
17. Bakx JC, van den Hoogen HJM, Deurenberg P, et al. Changes in serum total cholesterol levels over 18 years in a cohort of men and women. Prev Med 2000; 30: 138–45.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Bakx JC, van den Hoogen HJM, van den Bosch WJ, Thien T, van Weel C. Cardiovascular risk factors and disease in general practice: results of the Nijmegen Cohort Study. Br J Gen Pract 2002; 30: 138–45.

    OpenUrl
19. ↵
    Bakx JC, Stafleu A, van Staveren WA, van den Hoogen HJM, van Weel C. Long-term effect of nutritional counseling: a study in family medicine. Am J Clin Nutr 1997; 65(Suppl): 1946S–50S.

    OpenUrlPubMed
20. ↵
    van Ree JW, van Gerwen W, van den Hoogen HJM. Interventie bij een verhoogd risico op hart- en vaatziekten 1. Huisarts Wet 1985; 28: 21–4.

    OpenUrl
21. ↵
    van Ree JW, van Gerwen W, van den Hoogen HJM. Interventie bij een verhoogd risico op hart- en vaatziekten 2. Huisarts Wet 1985; 28: 53–8.

    OpenUrl
22. ↵
    Bakx JC, Oerlemans G, van den Hoogen H, van Weel C, Thien T. The influence of cuff size on blood pressure measurement. J Hum Hypertens 1997Jul; 11: 439–45.

    OpenUrlCrossRefPubMed
23. ↵
    Wannamethee SG, Sharper AG, Whincup PH, Walker M. Role of risk factors for major coronary heart disease events with increasing length of follow-up. Heart 1999; 81: 374–9.

    OpenUrlAbstract/FREE Full Text
24. ↵
    Hulshof KF, Brussaard JH, Kruizinga AG, Telman J, Löwik MRH. Socio-economic status, dietary intake and 10 y trends: the Dutch National Food Consumption Survey. Eur J Clin Nutr 2003; 57: 128–37.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    NHG-Standaard Cholesterol (1e herziening). HuisartsWet 1999; 42. Available from: http://nhg.artsennet.nl/upload/104/standaarden/M20/start.htm (accessed 8 May 2005).
26. ↵
    Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316 099 white men. Arch Int Med 1992; 152: 56–64.

    OpenUrlCrossRefPubMedWeb of Science
27. Jousilahti P, Erkki Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease. Circulation 1999; 99: 1165–72.

    OpenUrlAbstract/FREE Full Text
28. ↵
    Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353: 89–92.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    Kromhout D. Primordial prevention of cardiovascular disease risk in the Netherlands. Prev Med 1999; 29: S106–10.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    Bastuji-Garin S, Deverly A, Moyse D, et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 2002; 20: 1973–80.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Bakx C, Schwarte J, van den Hoogen H, Bor H, van Weel C. First myocardial infarction in a Dutch general practice population: trends in incidence from 1975 to 2003. Br J Gen Pract 2005; 55: 860–3.

    OpenUrlAbstract/FREE Full Text